ArticleOncoimmunology2021

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma.

R S A Goedegebuure et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.